The Jackson Laboratory Cancer Center has once again earned the renewal of its Cancer Center Support Grant from the National Cancer Institute. The Center integrates the three JAX campuses in Bar Harbor, Maine, Sacramento, Calif., and the new Jackson Laboratory for Genomic Medicine in Farmington, Conn. Under the leadership of JAX President and CEO Edison Liu, M.D., the Center is extending its research partnerships with major academic medical centers and with regional hospitals, including Children’s Hospital in Hartford, to move basic discovery science toward clinical application … more

Alexion Pharmaceuticals, Inc. and Cincinnati Children’s Hospital Medical Center have announced the establishment of a collaboration and fund for the advancement of research in rare disease. Under the terms of the agreement, Alexion will have the opportunity to fund selected research programs through the Alexion Rare Disease Innovation Fund. “Collaborations between industry and academia are important to drive innovation for patients suffering from rare diseases and we look forward to working with Cincinnati Children’s to advance our research programs, which are focused on developing life-transforming therapies for patients with devastating disorders,” said Martin Mackay, Ph.D., Executive Vice President and Global Head of Research and Development at Alexion … more